Date: 2015-05-12
Type of information: Grant
Company: Ixico (UK)
Investors: Innovate UK (UK)
Amount: £1 million
Funding type: grant
Planned used: Ixico has launched an Innovate UK funded project to support further development of its Assessa® medical device technology. Assessa® is a CE marked medical device to support accurate diagnosis of dementia through the automated quantitative assessment of structural brain MRI in combination with other clinical data such as demographics and information from genetic, biochemical, cognitive and functional tests. Assessa® is a web-based digital platform and is accessible to clinicians in Europe and Canada.
The project will develop digital technologies to quantify vascular disease burden in patients with CNS diseases to support more accurate differential diagnosis of CNS diseases in the clinic, enabling the design and execution of better targeted clinical trials. Brain scan and clinical data from patients with vascular disease will be tested for different algorithms that automatically quantify a subject\'s vascular disease burden against current visual assessments. The developed vascular disease biomarkers will be incorporated into the Assessa® platform providing clinicians with information that is clinically actionable and easy to interpret. As the lead partner, Ixico will be working alongside Imperial College London and Edinburgh University in the project which is part-funded by Innovate UK (formerly the Technology Strategy Board), the UK’s innovation agency. The project is expected to run for two years with a total investment of just over £1 million.
Others: * On May 12, 2015, Ixico, a brain health company, announced the launch of an Innovate UK grant funded project to support further development of its Assessa® medical device technology. The project is expected to run for two years with a total investment of just over £1 million.
Therapeutic area: CNS diseases
